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Objective: To update the recent knowledge of the microbiological causes of canine otitis
externa in Campania Region (Italy) and the antibiotic susceptibility patterns of the iso-
lated strains.
Methods: A total of 122 dogs were examined by otoscopy, and auricular swab samples
were collected from both ears in 74 dogs presenting clinical bilateral otitis and from
single ears in 48 dogs displaying clinical unilateral otitis. Cytological examination,
bacteriological analysis and antimicrobial susceptibility tests were performed.
Results: Thirty-one out of 122 dogs were positive for yeast species (25.4%, 95% con-
ﬁdence interval (CI): 18.2%–34.2%) with a higher prevalence of Malassezia pachy-
dermatis (21/31 isolates, 67.7%, CI: 48.5%–82.7%), and a total of 91 out of 122 dogs
were positive for bacterial species (74.6%; CI: 65.8%–81.8%) with a higher prevalence of
Staphylococcus pseudintermedius (45/143 isolates, 31.5%, CI: 24.1%–39.8%). These
results are the ﬁrst description of Streptococcus agalactiae-associated otitis. The yeasts
isolated showed high levels of susceptibility to all antifungal agents tested; on the con-
trary all the isolated bacterial strains were highly resistant to at least four out of ten
antimicrobial classes. Both Gram-positive and Gram-negative bacteria showed high
resistance to amoxicillin/clavulanate and kanamycin hence they are not recommended as
initial empirical therapy for the otitis treatment.
Conclusions: This update illustrates an increase in antibiotic resistances providing an
insight into the current knowledge of the therapeutic procedures followed on canine otitis
externa in Italy. It also emphasizes the importance of considering the results of the
microbiological and sensitivity tests to decide on an appropriate antibiotic therapy.1. Introduction
Otitis externa is the most common ear disease of dogs, being
up to 20% of the dog population affected by this disease. It has a
multifactorial etiology but it is predominantly a microbial infec-
tion. Clinical signs, such as exudates and frequently erythema,
oedema, offensive odour and pruritus are seen. Microorganisms
belonging to the normal microbial ﬂora of the auricular area can
become pathogenic when environmental and/or primary condi-
tions determine faster expression of their virulence factors.
Malassezia genus are commonly isolated in auricular
canal of dogs and cats, having otitis externa or in cases of
dermatitis disorders. The yeasts of the Malassezia genus arethe CC BY-NC-ND license (http://
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[1,2] and animal infections [3]. Particularly Malassezia
pachydermatis (M. pachydermatis) has been reported as the
predominant causative agent of canine otitis externa [4].
Furthermore, among bacterial agents, it is known that Staph-
ylococcus, Pseudomonas, Escherichia, and Proteus species are
considered important pathogens causing otitis externa in dogs [5].
Among Gram-positive bacteria, Staphylococcus pseudinterme-
dius, (S. pseudintermedius) a coagulase-positive staphylococcal
species, is frequently associated with pyoderma, otitis externa,
urinary tract infections, and opportunistically infected sites in
dogs [6]. Among Gram-negative bacteria, Pseudomonas aerugi-
nosa (P. aeruginosa) plays a major role in otitis externa also
because of the increasing number of multiresistant strains [7].
Regular treatment at home with disinfecting ear washes should
become part of the pet's grooming-routine with a correct antimicro-
bial therapy. It has been described a high sensitivity to beta-lactams
and aminoglycoside-aminocyclitols for Gram-positive bacteria,
while for Gram-negative bacteria has been suggested the use of
aminoglycoside-aminocyclitols, polymyxin B and enroﬂoxacin [8].
In recent decades it was reported that the high frequency of
multidrug-resistant of the isolated bacteria could become a high
risk factor for owners and veterinary professionals. Therefore, a
rational policy of antibiotic prescription in order to prevent the
selection of resistant strains is needed.
The purpose of the present study is to evaluate the presence
of microorganisms involved in otitis externa in dogs from
Campania Region, in southern Italy, in order to update data and
to investigate the presence of multi-resistant bacterial strains [9].2. Materials and methods
2.1. Samples
One hundred and twenty-two dogs with clinical signs of otitis
externa, such as local pain, pruritus, erythema, ear discharge and
desquamation of the epithelium, in at least one ear, were selected
to collect auricular swabs, during a period of two years, and a total
of 196 culture swabs were obtained. Precisely, samples were
collected from both ears in 74 dogswith clinical bilateral otitis and
unilaterally from 48 dogs with clinical unilateral otitis. Sterile
cotton-tipped applicator was used to collect samples of ear exu-
dates by inserting swabs into ear canal, rotating once through 360
and then rolling it out, and immediately transferred to Amies
transport medium (Oxoid Ltd, UK) and maintained at 4 C (not
longer than 24 h) until processing. The samples were presented for
screening at the Microbiology Laboratory of the Department of
Veterinary Medicine and Animal Production, University of
Naples Federico II (Italy). The canine population studied aged
from 2 months to 16 years and included 75 males and 47 females.
Dogs were excluded from the trial if they had previously
received (i) topical treatment (within 10 days), (ii) systemic treat-
ment with an antibiotic, antifungal or nonsteroidal anti-
inﬂammatory (within 10 days), (iii) a steroidal anti-inﬂammatory
treatment (within 14 days), or (iv) a long acting steroidal anti-
inﬂammatory drug systemically (within 60 days). Informed
consent was obtained from the owners of all dogs prior to their
participation in the study. All experimental procedures were
approved by The Local Ethical Committee of The Faculty of
Veterinary Medicine, University of Naples Federico II (author-
isation reference number Prot. 2011/0123330).2.2. Cytological analysis
For cytological analysis cotton-tipped swabs of ear canal
exudates were streaked onto glass slides, which were then heat
ﬁxed and stained with a modiﬁed Wright's stain (Diff Quik,
Dade Behring, Deerﬁeld, IL). All stained slides were examined
under a Nikon Eclipse E600 Microscopy (Nikon Instruments
Inc., Melville, NY) at 40× magniﬁcation. At least 10 ﬁelds were
examined, and a number of yeast cells per ﬁeld (> 5 yeast/ﬁeld)
represented excessive colonization by the organism and were
considered positive (infection). A number of bacteria 25 per
microscopy ﬁeld (40×) were considered positive (infection) as
previously described by Ginel et al. [10].
2.3. Microbiological analysis
Collected samples were plated on blood agar base supple-
mented with 5% sheep blood, selective medium used for the
isolation of Gram-positive microorganisms, on mannitol-salt
agar, selective medium to identify staphylococci, and on Mac-
Conkey agar, selective and differential medium to grow Gram-
negative bacteria, which were incubated aerobically at 37 C
for 24–48 h. Sabouraud's dextrose agar with chloramphenicol
was used to grow fungal ﬂora and was kept at 30 C for 7 days,
then stained with Gram stain and examined microscopically. The
plates were all microbiological media from Oxoid Ltd, UK. In
the case of yeasts of the genus Candida, we performed sub-
culture on Oxoid chromogenic candida agar media to differen-
tiate species of Candida. Further conﬁrmation of genus and
species of yeasts were obtained by biochemical identiﬁcation
using Remel RapID™ yeast plus identiﬁcation panel after pure
culture growth on Emmons agar (Oxoid).
Bacteria were identiﬁed by macroscopic observation of the
colonies, Gram staining, standard laboratory methodologies
(catalase, staphylocoagulase tube test, aesculin), and miniatur-
ized biochemical tests API system (bioMe´rieux SA, Marcy
L'Etoile, France). The species identiﬁcation by miniaturized
biochemical tests was accepted when probability was > 88%. b-
haemolytic cocci strains were identiﬁed as group B [Strepto-
coccus agalactiae (S. agalactiae)] or group C Streptococcus
dysgalactiae (S. dysgalactiae), using a streptococcus grouping
kit (Streptex, Mitsubishi Chemical Medience Corporation,
Tokyo, Japan). The presence of the mecA gene was detected by
growth on oxacillin-containing media (2 mg/L), agar diffusion
with oxacillin disks (5 mg) and positive latex agglutination test
(PBP20 Test. Oxoid Ltd, UK).
2.4. Antimicrobial susceptibility testing
The antimicrobial susceptibility patterns of isolated bacterial
strains were determined by disk diffusion test using Mueller–
Hinton agar (Oxoid Ltd, UK). The inhibitory zone diameters
obtained around the antibiotic disks were measured after
incubation for 24 h at 37 C and evaluated according to the
Clinical and Laboratory Standards Institute [11]. An oxacillin
(methicillin) susceptibility test of all isolates was performed by
oxacillin disk diffusion and if assayed, the minimal inhibitory
concentration was determined by standard methods.
Ten drug classes were included in this study, using com-
mercial disks containing the drugs (Oxoid Ltd, UK). Penicillins
were represented by benzylpenicillin (penicillin G) (10 IU),
Table 2
Number and percentage of isolated bacteria from dogs with otitis externa.
Bacteria No. of
isolates
Percent
(%)
95% CI
Staphylococcaceae S. pseudintermedius 45 31.5 24.1–39.8
S. aureus 7 4.9 2.2–10.2
S. xylosus 7 4.9 2.2–10.2
Staphylococcus
chromogenes
4 2.8 0.9–7.4
S. hyicus 3 2.1 0.5–6.5
Staphylococcus
capitis
2 1.4 0.2–5.5
Staphylococcus
epidermidis
1 0.7 0.0–4.4
Gemella
morbillorum
2 1.4 0.2–5.5
Pseudomonadaceae P. aeruginosa 23 16.1 10.7–23.4
Pseudomonas
putrida
4 2.8 0.9–7.4
Pseudomonas
luteola
2 1.4 0.2–5.5
Pseudomonas
ﬂuorescens
1 0.7 0.0–4.4
Enterobacteriaceae P. mirabilis 9 6.3 3.1–12.0
Escherichia
coli
6 4.2 1.7–9.3
Enterobacter
cloacae
1 0.7 0.0–4.4
Citrobacter
braaakii
1 0.7 0.0–4.4
Klebsiella
pneumoniae
1 0.7 0.0–4.4
Stretococcaceae S. mitis 4 2.8 0.9–7.4
Streptococcus
canis
1 0.7 0.0–4.4
S. agalactiae 1 0.7 0.0–4.4
S. dysgalactiae 1 0.7 0.0–4.4
Streptococcus
sanguinis
1 0.7 0.0–4.4
Streptococcus
equinus
1 0.7 0.0–4.4
Streptococcus
simulans
1 0.7 0.0–4.4
Enterococcaceae Enterococcus
faecalis
4 2.8 0.9–7.4
Luisa De Martino et al./Asian Pac J Trop Biomed 2016; 6(5): 384–389386ampicillin (10 mg), amoxicillin-clavulanic acid combination
(20 + 10 mg), and oxacillin (1 mg). Furthermore, cephalosporins
(ﬁrst generation) were represented by cefadroxil (30 mg),
cephalosporins (third generation) were represented by ceftriax-
one (30 mg), ﬂuoroquinolones by enroﬂoxacin (5 mg) and nor-
ﬂoxacin (10 mg), aminoglycosides by gentamicin (10 mg),
kanamycin (30 mg), neomycin (30 mg) and streptomycin (10 mg),
glycopeptides by vancomycin (30 mg), macrolides by erythro-
mycin (15 mg), and polypeptides by bacitracin (0.05 mg) and
colistin sulfate (10 mg). In addition, tetracyclines were assayed
as doxycycline (30 mg) and tetracycline (10 mg) and lincosa-
mides as lincomycin (2 mg). Finally, we assayed also a sul-
phonamide (sulfamethoxazole/trimethoprim, 50 mg). The choice
of drugs depended by strains and clinical use. The strains were
categorized as sensitive or resistant to the drug, intermediate
susceptibility was regarded as resistant, and only the resistances
are reported in the results.
Antifungal susceptibility was performed by disc diffusion
method using antimycotic sensitivity test agar. Discs used were
amphotericin B (100 IU), ﬂuconazole (10 mg), clotrimazole
(10 mg), itraconazole (10 mg), miconazole (10 mg) was measured
as for the instruction manual (HiMedia). ATCC strain of
Candida albicans was used as control.
2.5. Statistical analysis
Statistical analysis of bacteriological examination results was
performed by One-way ANOVA with Bonferroni post-test using
GraphPad InStat Version 3.00 for Windows 95 (GraphPad
Software Inc., La Jolla, CA). P value of less than 0.05 was
regarded as statistically signiﬁcant.
3. Results
The screening in 196 samples performed by cytological ex-
amination showed a prevalence signiﬁcantly higher (P < 0.001)
of bacterial compared to fungal otitis externa, both in mono-
lateral (37/11) and bilateral infection (53/21). Furthermore, the
cases of bilateral otitis (74/122) was signiﬁcantly higher
(P < 0.001) respect to monolateral otitis (48/122) regardless of
the microorganism that causes disease.
Yeasts were detected in a total of 53 swabs samples with
M. pachydermatis presenting the highest prevalence (67.74%)
followed by Candida parapsilosis (12.90%), as shown in
Table 1. These diseased dogs after local therapy with micona-
zole and prednisolone acetate, for at least 2 weeks, showed a
remission of symptoms.Table 1
Number and percentage of isolated yeasts from dogs with otitis externa.
Yeasts No. of isolates Percent (%) 95% CI
M. pachydermatis 21 67.74 48.54–82.68
Candida parapsilosis 4 12.90 4.22–30.76
Candida tropicalis 2 6.45 1.13–22.84
Candida glabrata 1 3.23 0.17–18.51
Candida albicans 1 3.23 0.17–18.51
Aspergillus niger 1 3.23 0.17–18.51
Exophiala spp 1 3.23 0.17–18.51
Total 31
CI: Conﬁdence interval.
Enterococcus
avium
1 0.7 0.0–4.4
Enterococcus
durans
1 0.7 0.0–4.4
Enterococcus
faecium
1 0.7 0.0–4.4
Other Micrococcus
spp.
1 0.7 0.0–4.4
Kocuria
varians
3 2.1 0.5–6.5
Aerococcus
viridans
1 0.7 0.0–4.4
Pasteurella
pneumotropica
1 0.7 0.0–4.4
Total 143
S. mitis: Streptococcus mitis; S. xylosus: Staphylococcus xylosus; S.
hyicus: Staphylococcus hyicus.Table 2 shows the number and percentage of isolated bacteria.
The most frequently isolated strain was S. pseudintermedius(31.5%; 95% CI: 24.1%–39.8%) followed by P. aeruginosa
(16.1%; 95% CI: 10.7%–23.4%), Proteus mirabilis (P. mirabilis)
(6.3%; 95% CI: 3.1%–12.0%), and Staphylococcus aureus
(S. aureus) (4.9%; 95% CI: 2.2%–10.2%). Moreover, a total of
four out of forty-ﬁve S. pseudintermedius (8.9%; 95% CI: 2.9%–
22.1%) were positive for themecA gene as conﬁrmed by oxacillin
agar screening test, oxacillin diffusion test and latex agglutination
test. A total of 10 bacteria belonging to Streptococcaceae group
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otitis was observed.
Table 3 shows the results of the antimicrobial susceptibility
tests of the most frequently isolated strains from dogs with otitis
externa. However, S. pseudintermedius, S. aureus and
S. xylosus, which represented 85.5% of staphylococcal strains,
were variously resistant to all antimicrobial classes. Further-
more, 4/45 (8.9%; 95% CI: 2.9%–22.1%) S. pseudintermedius,
6/7 (85.7%; 95% CI: 42.0%–99.2%) S. xylosus, 3/4 (75.0%;
95% CI: 21.9%–98.7%) Staphylococcus chromogenes, and 3/3
(100%; 95% CI: 31.0%–96.8%) S. hyicus strains isolates were
methicillin/oxacillin and penicillin resistant using disk diffusion
tests and could be cultivated on oxacillin resistant screening agar
base (data not shown). Among thirty Pseudomonas spp strains,
the most frequently isolated P. aeruginosa (23 strains) presented
evident multidrug resistant proﬁles, with over 73% resistance to
penicillins (ampicillin and amoxicillin-clavulanate), over 65% to
aminoglycosides (kanamycin, neomycin, streptomycin) and tet-
racyclines (doxycycline and tetracycline), and over 43% resis-
tance to enroﬂoxacin, 100% to bacitracin and over 69% to
lincomycin. Two isolates of Pseudomonas luteola and one of
Pseudomonas ﬂuorescens showed a substantial multi-resistance
(data not shown). It is noteworthy that multidrug resistant
P. mirabilis strains were observed.
The most of streptococcal strains (S. mitis, S. agalactiae and
Streptococcus canis) were also multi-resistant. In addition, sur-
prisingly, the only S. agalactiae strain, generally considered
uniformly susceptible to penicillins, was not susceptible to
penicillin G with a minimal inhibitory concentration of 128 mg/
L, and showed simultaneous resistance to ceftriaxone, erythro-
mycin, tetracycline, lincomycin, sulfamethoxazole/trimetho-
prim, other than others b-lactams tested. S. dysgalactiae strain
isolated was resistant to erythromycin and tetracycline (data not
shown).Table 3
Antimicrobial susceptibility of the most frequently isolated strains from dog
Drug
S. pseudintermedius
(n = 45)
P. aerugino
(n = 23)
Penicillin G 57.7 NA
Oxacillin 8.9 NA
Ampicillin NA 73.9
Amoxicillin-clavulanic acid 35.5 78.3
Ceftriaxone 11.1 39.1
Norﬂoxacin 11.1 0.0
Enroﬂoxacin 15.5 43.5
Gentamicin 11.1 8.7
Kanamycin 62.2 87.0
Neomycin 31.1 65.2
Streptomycin 46.6 78.3
Vancomycin 11.1 52.2
Erythromycin 31.1 NA
Bacitracin 68.8 100.0
Doxycycline 15.5 78.3
Tetracycline 35.5 69.6
Lincomycin 20.0 69.6
Sulfamethoxazole/
trimethoprim
46.6 17.4
NA: Not assayed.4. Discussion
Ear disease is one of the most common conditions present in
pets, and the infections can be caused by both bacterial and
fungal origin. Malassezia spp are normal commensals and oc-
casional pathogens of the skin for many veterinary species,
present in up to 40% of canine otitis cases [12]. Herein, we
reported a prevalence of yeast species of 25.4% with a higher
prevalence of M. pachydermatis (67.74%).
S. pseudintermedius represents the majority of all coccal
microorganism isolated, whereas Gram-negative bacteria as
P. aeruginosa, P. mirabilis and others, are also included among
the most common isolates that may cause canine otitis externa
[5,12]. In the present study, in agreement with the above
mentioned ﬁndings, the most commonly identiﬁed bacteria
were S. pseudintermedius, P. aeruginosa and P. mirabilis.
Furthermore, most S. pseudintermedius, S. xylosus, and
S. hyicus strains isolates were methicillin/oxacillin and
penicillin resistant. We reported no isolation of Staphylococcus
schleiferi which is considered as a potential pathogen in dogs
and is often oxacillin resistant [13].
The members of the Staphylococcus genus have a high fre-
quency of conjugation and frequently acquire plasmids that
encode antimicrobial resistance, and the production of the
enzyme b-lactamase is the major mechanism by which staphy-
lococci acquire resistance [14]. The reservoir of mecA gene is
likely larger in coagulase-negative-staphylococci than in
S. aureus [15], as more times reported, both in human clinical
isolates [16] and in various animal species [17,18].
The literature reports a higher interest for coagulase-positive
staphylococci, but also the coagulase-negative staphylococci,
which have long been considered as nonpathogenic, recently have
assumed an important role as pathogens because of their
increasing incidence as cause of bacteremia. Interestingly, amongs with otitis externa.
Percentage of resistance
sa P. mirabilis
(n = 9)
S. mitis (n = 4) Enterococcus faecalis
(n = 4)
NA 0.0 50.0
NA 0.0 25.0
33.3 NA 75.0
33.3 0.0 50.0
0.0 25.0 NA
0.0 25.0 50.0
0.0 25.0 50.0
11.1 25.0 75.0
22.2 50.0 50.0
33.3 25.0 50.0
55.5 25.0 75.0
44.4 0.0 25.0
NA 25.0 NA
66.6 75.0 50.0
55.5 25.0 50.0
77.7 50.0 75.0
66.6 50.0 75.0
55.5 25.0 NA
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resistant Staphylococcus epidermidis resistant to 6/17 antimicro-
bial drugs, which represents serious evidence of emergence of
multidrug-resistant strains in dog infections. A substantial multi-
resistance was also found in others Gram-positive bacteria iso-
lates, as streptococci and enterococci. The only S. agalactiae
strain showed a reduced susceptibility to penicillin G. There is
little information on the nature of mechanism of resistance. The
most likely hypothesis is the modiﬁcation of amino acid sequence
of penicillin-binding protein [19]. However, S. agalactiae (groupB
streptococci) is an emerging pathogen in immunocompromised
adults and a major cause of neonatal pneumonia, sepsis, and
meningitis; it has been isolated in bovine mammary gland
infections, and in companion animals. Its surface-localized peni-
cillin-binding protein 1a, encoded by ponA, is known to be an
important virulence factor in infection [20]. Traditionally, b-
lactams are the ﬁrst-line agents against S. agalactiae and resis-
tance is rarely reported [21,22]. Our case demonstrated that the
resistances, overall to b-lactams and cephalosporins, of this
strain request further studies.
The rods involved in canine otitis externa are frequently
P. aeruginosa, although P. mirabilis, or other Gram-negative
bacteria such as Escherichia coli, Corynebacterium species or,
infrequently, Klebsiella and Enterobacter spp., may occur. Our
results indicated that in our region, the predominant Gram-negative
bacteria were P. aeruginosa and P. mirabilis displaying a high rate
of resistance to each of the antimicrobials tested. Themost frequent
antimicrobial classes used in small animals in veterinary medicine
include penicillins, cephalosporins, macrolides, lincosamides,
fusidic acid, tetracyclines, chloramphenicol, potentiated sulpho-
namides, aminoglycosides and ﬂuoroquinolones. Aminoglyco-
sides, such as gentamicin and neomycin, are routinely used for
topical therapy in canine otitis mainly caused by P. aeruginosa
[5,7,12,23], but our Pseudomonas spp. isolates presented multidrug
resistant proﬁles with very high resistance to aminoglycosides,
other than penicillins and tetracyclines. Our results combined
with data from the literature support the premise that
antimicrobials should be selected basically on bacterial culture
and antimicrobial susceptibility test. Until recently, multi-
resistance was overall seen in Gram-positive bacteria [24,25].
However, the recent rapid international spread of multi-resistant
Gram-negative bacteria [26], is much more ominous, and the
optimal management of serious infections with these bacteria
remains to be determined. A recent study has reported that
administration of a topical bacteriophage mixture leads to lysis of
P. aeruginosa in the ear without apparent toxicity and that might
potentially became a convenient and effective treatment for
P. aeruginosa-associated otitis in dogs [27].
Consistent with previous reports, this study is a further
conﬁrmation that coagulase-positive species of staphylococcal
strains are the most causative microorganisms of otitis externa in
dogs. In particular, both S. pseudintermedius and methicillin/
oxacillin-resistant S. pseudintermedius strains represent a
group of emerging pathogens to be monitored as opportunistic
animal pathogens with zoonotic capabilities. In addition, to our
knowledge, this is the ﬁrst report of canine otitis correlated to
S. agalactiae, a bacteria isolated mainly from humans and
bovine sources. Surprisingly, this isolate presented a simulta-
neous resistance to more different classes of antibiotics other
than b-lactams. Thus, our data emphasize the importance: (i) to
study proﬁles and genetic characteristics of GBS colonizing the
pet animals, (ii) to investigate the possible transmission fromhuman to dog, and (iii) to focus on the prevention and treatment
of GBS infections.
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